Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial

Journal:

Nature Communications

Published:

2025-12-03

DOI:

10.1038/s41467-025-67087-8

Affiliations:

4

Authors:

23

Go to article

Institutions	Authors	Share
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	16.000000 16.000000	0.70
Massachusetts General Hospital (MGH), United States of America (USA)	3.000000	0.13
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA)	2.000000	0.09
Beth Israel Deaconess Medical Center (BIDMC), United States of America (USA)	2.000000	0.09

Interested in Oncology and Carcinogenesis?